# Greenoaks Capital

Greenoaks Capital is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** North America
- **Address:** San Francisco, CA, United States
- **Founded:** 2010
- **Assets under management:** $10B+ (Altss estimate)
- **Website:** www.greenoaks.com

## Regulatory record

- **Reports private funds:** No

## About

Greenoaks LLC (Greenoaks) and its affiliates operate a business that provides investment services. The firm conducts investment-related research and due diligence on current or potential investments and other corporate transactions. It also deals with representatives of vendors, business partners, and portfolio companies.

## Sectors

- Enterprise Software
- FinTech
- AI/ML
- Digital Health
- Mobility & Transportation
- Cybersecurity
- ClimateTech

## Offices

- London, United Kingdom

## People

- Neil Mehta — Founder & Managing Partner
- Benny Peretz — Partner

## Questions

### Who runs investment decisions at Greenoaks Capital?

Neil Mehta, the founder and managing partner, has final authority over investment decisions and portfolio construction. He is supported by partner Benny Peretz and a lean investment team. The firm's concentrated portfolio — often fewer than 20 core positions — means Mehta is directly involved in every material capital allocation.

### How does Greenoaks source proprietary deal flow?

Greenoaks relies primarily on founder relationships and repeat backing of entrepreneurs across successive ventures. Mehta's early bets on companies like Stripe and Brex established a reputation that generates inbound deal flow. The firm does not operate a traditional outbound sourcing machine; its concentration model means it pursues only a handful of new investments per year.

### Does Greenoaks participate in fund commitments or only direct deals?

Greenoaks executes direct equity and equity-linked investments in operating companies, not fund commitments to other managers. The firm has occasionally purchased secondary stakes to increase ownership in existing portfolio positions, but it does not allocate capital to third-party venture capital or private equity funds.

### What investment stages does Greenoaks typically target?

The firm invests primarily at the expansion and late stages, writing first checks that range from $50 million to over $500 million. Greenoaks will occasionally enter at the Series B stage for companies it believes are category-defining, and it has the mandate to hold positions through IPO and for years afterward rather than distributing public stock to its limited partners.

### Which sectors does Greenoaks explicitly avoid?

Greenoaks has historically avoided capital-intensive industries such as semiconductors, traditional manufacturing, and brick-and-mortar retail. The firm does not invest in biotechnology or therapeutic drug development, nor has it shown interest in oil and gas, mining, or other extractive industries. Its portfolio concentrates exclusively on technology-enabled business models with negative working capital dynamics and high gross margins.

### What is Greenoaks's known posture on co-investments alongside external GPs?

Greenoaks regularly co-invests alongside crossover funds, sovereign wealth funds, and late-stage venture firms such as Tiger Global, D1 Capital, and Sequoia Capital. The firm does not operate a formal co-investment program for its limited partners but will structure syndicated rounds where multiple institutional investors participate on equal terms.

## Related profiles

- [Greenmount Capital](https://altss.com/profile/greenmount-capital)
- [Green One Capital](https://altss.com/profile/green-one-capital)

---

Last updated: 2026-08-11T15:06:57.816Z

Canonical page: https://altss.com/profile/greenoaks-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology